CIK 0001357459
- Non-accelerated filer
- Smaller reporting company
PALISADE BIO, INC.
Sign in to watch- Ticker
- PALI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 522007292
- Phone
- +1 858-704-4900
- Business address
- 7750 EL CAMINO REAL, SUITE 5200, CARLSBAD, CA, 92009
- Former names
- PALISADE BIO, INC., Seneca Biopharma, Inc., Neuralstem, Inc.
- Open-market buys, last 90 days
- $28,800
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$28,800. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 87 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-27 | Hallam Thomas Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +20,392 | 20,392 | ||
| 2021-04-27 | Hallam Thomas Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +15,002 | 15,002 | ||
| 2021-04-27 | Hallam Thomas Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +12,294 | 12,294 | ||
| 2021-04-27 | Hallam Thomas Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +27,190 | 27,190 | ||
| 2021-04-27 | Finley John David Chief Financial Officer | Grant or award | +2,396 | 2,396 | ||
| 2021-04-27 | Finley John David Chief Financial Officer | Grant or award | +26,322 | 26,322 | ||
| 2021-04-27 | Finley John David Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +10,418 | 10,418 | ||
| 2021-04-27 | Finley John David Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +9,516 | 9,516 | ||
| 2021-04-27 | Finley John David Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +52,068 | 52,068 | ||
| 2021-04-27 | Finley John David Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +14,708 | 14,708 | ||
| 2021-04-27 | Finley John David Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +5,662 | 5,662 | ||
| 2021-04-27 | Finley John David Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +19,033 | 19,033 | ||
| 2021-04-27 | Finley John David Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +9,702 | 9,702 | ||
| 2021-04-27 | Finley John David Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +7,952 | 7,952 | ||
| 2021-04-27 | Finley John David Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +2,595 | 2,595 | ||
| 2021-04-27 | Finley John David Chief Financial Officer | Grant or award · Warrant (Right to Buy) | +95 | 95 | ||
| 2021-04-27 | Finley John David Chief Financial Officer | Grant or award · Warrant (Right to Buy) | +51 | 51 | ||
| 2021-04-27 | Finley John David Chief Financial Officer | Grant or award · Warrant (Right to Buy) | +49 | 49 | ||
| 2021-04-27 | Finley John David Chief Financial Officer | Grant or award · Warrant (Right to Buy) | +339 | 339 | ||
| 2021-04-27 | Finley John David Chief Financial Officer | Grant or award · Warrant (Right to Buy) | +503 | 503 |
Page 15 of 21 · 409 trades